Financial Ratios Cardiol Therapeutics Inc.

Stocks

CRDL

CA14161Y2006

Biotechnology & Medical Research

Market Closed - Toronto S.E. 16:00:00 2026-08-28 EDT			5-day change	1st Jan Change
2.700 ^CAD	-5.92%		+4.65%	+106.11%

08-12	Cardiol Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

a1721add3951b481f2e432729.WN5tYbPtJ8Bsg0QbUanU5zPgH8ShZferuupuOjfjlz4.CYY-JvGZF_I28QtdJvi_qnqWZqyREILN2YdbXmOLpAosjlUZgZ8RpTrRcA

Published financial data: CARDIOL THERAPEUTICS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Revenues	78.76K	-	-	-	-
Total Revenues	78.76K	-	-	-	-
Gross Profit	78.76K	-	-	-	-
Selling General & Admin Expenses, Total	27.87M	22.37M	15.56M	26.26M	20.3M
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	10.87M	18.96M	14.22M	14.01M	14.02M
Depreciation & Amortization - (IS)	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses, Total	38.74M	41.34M	29.79M	40.28M	34.32M
Operating Income	-38.66M	-41.34M	-29.79M	-40.28M	-34.32M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	106K	1.24M	2.04M	1.19M	726K
Net Interest Expenses	106K	1.24M	2.04M	1.19M	726K
Currency Exchange Gains (Loss)	1.89M	2.76M	-713K	2.14M	-1.18M
Other Non Operating Income (Expenses)	5.03M	6.41M	331K	266K	952K
EBT, Excl. Unusual Items	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
EBT, Incl. Unusual Items	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Earnings From Continuing Operations	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Net Income to Company	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Net Income - (IS)	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Net Income to Common Incl Extra Items	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Net Income to Common Excl. Extra Items	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Per Share Items
Net EPS - Basic	-0.73	-0.49	-0.44	-0.51	-0.39
Basic EPS - Continuing Operations	-0.73	-0.49	-0.44	-0.51	-0.39
Basic Weighted Average Shares Outstanding	43.22M	62.51M	64.46M	71.57M	86.99M
Net EPS - Diluted	-0.73	-0.49	-0.44	-0.51	-0.39
Diluted EPS - Continuing Operations	-0.73	-0.49	-0.44	-0.51	-0.39
Diluted Weighted Average Shares Outstanding	43.22M	62.51M	64.46M	71.57M	86.99M
Normalized Basic EPS	-0.46	-0.31	-0.27	-0.32	-0.24
Normalized Diluted EPS	-0.46	-0.31	-0.27	-0.32	-0.24
Supplemental Items
EBITDA	-38.48M	-41.16M	-29.59M	-40.11M	-34.28M
EBITA	-38.58M	-41.25M	-29.7M	-40.21M	-34.32M
EBIT	-38.66M	-41.34M	-29.79M	-40.28M	-34.32M
Normalized Net Income	-19.77M	-19.33M	-17.58M	-22.92M	-21.14M
Interest on Long-Term Debt	12.93K	9.23K	15.93K	25.72K	22.37K
Supplemental Operating Expense Items
General and Administrative Expenses	27.87M	22.37M	15.56M	26.26M	20.3M
Research And Development Expense From Footnotes	10.87M	18.96M	14.22M	14.01M	14.02M
Stock-Based Comp., R&D Exp. (Total)	599K	631K	350K	1.36M	1.48M
Stock-Based Comp., G&A Exp. (Total)	7.9M	4.38M	3.81M	12.92M	9.22M
Stock-Based Comp., Other (Total)	4.11M	525K	16.45K	-	-
Total Stock-Based Compensation	12.61M	5.54M	4.17M	14.28M	10.7M

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Assets
Cash And Equivalents	83.9M	59.47M	34.93M	30.58M	21.42M
Total Cash And Short Term Investments	83.9M	59.47M	34.93M	30.58M	21.42M
Accounts Receivable, Total	65.74K	210K	-	-	-
Other Receivables	341K	270K	280K	362K	226K
Total Receivables	407K	480K	280K	362K	226K
Inventory	339K	-	-	-	-
Prepaid Expenses	2.5M	1.49M	941K	727K	1.86M
Total Current Assets	87.14M	61.44M	36.15M	31.67M	23.5M
Gross Property Plant And Equipment	714K	789K	994K	968K	993K
Accumulated Depreciation	-357K	-493K	-657K	-773K	-875K
Net Property Plant And Equipment	356K	296K	337K	196K	118K
Other Intangibles, Total	379K	295K	210K	0	-
Total Assets	87.88M	62.03M	36.7M	31.86M	23.62M
Liabilities
Accounts Payable, Total	4.14M	8.35M	7.62M	6.98M	3.48M
Accrued Expenses, Total	718K	985K	417K	-	-
Current Portion of Leases	44.71K	50.45K	15.81K	33.01K	38.35K
Other Current Liabilities	6.66M	420K	238K	-	2.14M
Total Current Liabilities	11.57M	9.8M	8.3M	7.01M	5.66M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	72.87K	22.42K	159K	126K	87.18K
Total Liabilities	11.64M	9.83M	8.45M	7.14M	5.74M
Common Stock, Total	143M	148M	149M	179M	202M
Additional Paid In Capital	12.66M	15.59M	18.79M	24.65M	29.08M
Retained Earnings	-83.52M	-114M	-143M	-179M	-213M
Comprehensive Income and Other	4.18M	3.52M	3.52M	-	-
Total Common Equity	76.24M	52.2M	28.25M	24.73M	17.88M
Total Equity	76.24M	52.2M	28.25M	24.73M	17.88M
Total Liabilities And Equity	87.88M	62.03M	36.7M	31.86M	23.62M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	61.93M	64.1M	68.27M	82.61M	112M
ECS Total Common Shares Outstanding	61.92M	64.04M	65.35M	82.61M	100M
Book Value / Share	1.23	0.82	0.43	0.3	0.18
Tangible Book Value	75.86M	51.91M	28.04M	24.73M	17.88M
Tangible Book Value Per Share	1.23	0.81	0.43	0.3	0.18
Total Debt	118K	72.87K	174K	159K	126K
Net Debt	-83.78M	-59.4M	-34.76M	-30.42M	-21.29M
Account Code - Inventory Valuation	8	8	-	3	3
Machinery, Total	276K	351K	415K	390K	414K
Full Time Employees	-	-	-	18	18

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Net Income	-31.64M	-30.93M	-28.13M	-36.68M	-33.82M
Depreciation & Amortization - CF	136K	135K	164K	163K	102K
Amortization of Goodwill and Intangible Assets - (CF)	84.44K	84.44K	84.44K	63.33K	-
Depreciation & Amortization, Total	220K	220K	248K	226K	102K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	83.42K	1.36M	-	147K	-
Stock-Based Compensation (CF)	12.61M	5.54M	4.17M	14.28M	10.7M
Other Operating Activities, Total	-4.9M	-9.15M	-928K	-2.1M	-105K
Change In Accounts Receivable	-59.95K	-144K	67.18K	42.38K	44.64K
Change In Inventories	17.97K	-	-	-	-
Change In Accounts Payable	2.39M	4.47M	-1.29M	-1.06M	264K
Change in Other Net Operating Assets	-2.27M	1.42M	680K	90.8K	-1.04M
Cash from Operations	-23.55M	-27.22M	-25.18M	-25.06M	-23.85M
Capital Expenditure	-12.92K	-74.71K	-64.31K	-21.29K	-24.48K
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-12.92K	-74.71K	-64.31K	-21.29K	-24.48K
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-51.92K	-53.93K	-55.38K	-41.53K	-55.38K
Total Debt Repaid	-51.92K	-53.93K	-55.38K	-41.53K	-55.38K
Issuance of Common Stock	98.72M	-	-	21.53M	16.07M
Other Financing Activities, Total	-5.23M	-	-	-2.65M	-477K
Cash from Financing	93.44M	-53.93K	-55.38K	18.84M	15.54M
Foreign Exchange Rate Adjustments	-	2.92M	762K	1.89M	-824K
Net Change in Cash	69.87M	-24.43M	-24.54M	-4.35M	-9.16M
Supplemental Items
Levered Free Cash Flow	-4.61M	-20.64M	-14.99M	-11.86M	-13.03M
Unlevered Free Cash Flow	-4.61M	-20.64M	-14.99M	-11.86M	-13.03M
Change In Net Working Capital	-6.74M	493K	728K	1.17M	2.36M
Net Debt Issued / Repaid	-51.92K	-53.93K	-55.38K	-41.53K	-55.38K

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Profitability
Return on Assets	-46.58	-34.47	-37.71	-73.43	-77.31
Return on Total Capital	-53.83	-40.17	-46.14	-94.44	-100.01
Return On Equity %	-70.69	-48.16	-69.93	-138.47	-158.75
Return on Common Equity	-70.69	-48.16	-69.93	-138.47	-158.75
Margin Analysis
Gross Profit Margin %	100	-	-	-	-
SG&A Margin	35.39K	-	-	-	-
EBITDA Margin %	-48.86K	-	-	-	-
EBITA Margin %	-48.98K	-	-	-	-
EBIT Margin %	-49.09K	-	-	-	-
Income From Continuing Operations Margin %	-40.17K	-	-	-	-
Net Income Margin %	-40.17K	-	-	-	-
Net Avail. For Common Margin %	-40.17K	-	-	-	-
Normalized Net Income Margin	-25.11K	-	-	-	-
Levered Free Cash Flow Margin	-5.85K	-	-	-	-
Unlevered Free Cash Flow Margin	-5.85K	-	-	-	-
Asset Turnover
Asset Turnover	0	-	-	-	-
Fixed Assets Turnover	0.19	-	-	-	-
Short Term Liquidity
Current Ratio	7.53	6.27	4.36	4.52	4.16
Quick Ratio	7.29	6.11	4.24	4.41	3.83
Operating Cash Flow to Current Liabilities	-2.04	-2.78	-3.04	-3.58	-4.22
Long Term Solvency
Total Debt/Equity	0.15	0.14	0.62	0.64	0.7
Total Debt / Total Capital	0.15	0.14	0.61	0.64	0.7
LT Debt/Equity	0.1	0.04	0.56	0.51	0.49
Long-Term Debt / Total Capital	0.1	0.04	0.56	0.5	0.48
Total Liabilities / Total Assets	13.24	15.84	23.04	22.39	24.31
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-0	-0	-0.01	-0	-0
Net Debt / EBITDA	2.18	1.44	1.18	0.76	0.62
Total Debt / (EBITDA - Capex)	-0	-0	-0.01	-0	-0
Net Debt / (EBITDA - Capex)	2.18	1.44	1.17	0.76	0.62
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	87.72	6.94	-28.1	35.57	-14.23
EBITA, 1 Yr. Growth %	87.23	6.92	-28	35.39	-14.35
EBIT, 1 Yr. Growth %	86.87	6.91	-27.94	35.22	-14.8
Earnings From Cont. Operations, 1 Yr. Growth %	53.28	-2.24	-9.06	30.39	-7.79
Net Income, 1 Yr. Growth %	53.28	-2.24	-9.06	30.39	-7.79
Normalized Net Income, 1 Yr. Growth %	53.28	-2.24	-9.06	30.39	-7.79
Diluted EPS Before Extra, 1 Yr. Growth %	5.88	-32.4	-11.82	17.45	-24.14
Accounts Receivable, 1 Yr. Growth %	-	219.33	-	-	-
Inventory, 1 Yr. Growth %	-5.03	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-25.66	-17.04	13.97	-41.97	-39.62
Total Assets, 1 Yr. Growth %	452.92	-29.41	-40.83	-13.18	-25.87
Tangible Book Value, 1 Yr. Growth %	492.34	-31.57	-45.99	-11.8	-27.7
Common Equity, 1 Yr. Growth %	474.5	-31.53	-45.89	-12.45	-27.7
Cash From Operations, 1 Yr. Growth %	156.39	15.64	-7.49	-0.47	-4.81
Capital Expenditures, 1 Yr. Growth %	-68.19	478.42	-13.92	-66.9	15
Levered Free Cash Flow, 1 Yr. Growth %	185.99	347.83	-27.41	-20.86	11.21
Unlevered Free Cash Flow, 1 Yr. Growth %	185.99	347.83	-27.41	-20.86	11.21
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	80.85	41.83	-12.27	-1.27	7.63
EBITA, 2 Yr. CAGR %	80.75	41.49	-12.26	-1.27	7.49
EBIT, 2 Yr. CAGR %	80.3	41.34	-12.23	-1.29	7.34
Earnings From Cont. Operations, 2 Yr. CAGR %	52.05	22.41	-5.71	8.89	9.65
Net Income, 2 Yr. CAGR %	52.05	22.41	-5.71	8.89	9.65
Normalized Net Income, 2 Yr. CAGR %	52.05	22.41	-5.71	8.89	9.65
Diluted EPS Before Extra, 2 Yr. CAGR %	17.53	-15.4	-22.79	1.77	-5.61
Inventory, 2 Yr. CAGR %	-76.62	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-21.87	-21.47	-2.76	-18.68	-40.81
Total Assets, 2 Yr. CAGR %	138.08	97.56	-35.38	-28.33	-19.78
Tangible Book Value, 2 Yr. CAGR %	131.75	101.32	-39.21	-30.98	-20.15
Common Equity, 2 Yr. CAGR %	127.95	98.34	-39.13	-31.17	-20.44
Cash From Operations, 2 Yr. CAGR %	43.86	72.67	3.43	-4.05	-2.67
Capital Expenditures, 2 Yr. CAGR %	-82.55	35.65	123.14	-46.62	-38.3
Levered Free Cash Flow, 2 Yr. CAGR %	-12.8	257.88	80.3	-24.2	-6.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	-12.79	257.88	80.3	-24.2	-6.77
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	81.04	51.8	13.09	1.43	-5.91
EBITA, 3 Yr. CAGR %	81.12	51.73	12.96	1.39	-5.95
EBIT, 3 Yr. CAGR %	80.48	51.47	12.91	1.37	-6.02
Earnings From Cont. Operations, 3 Yr. CAGR %	25.79	31.24	10.87	5.05	3.02
Net Income, 3 Yr. CAGR %	25.79	31.24	10.87	5.05	3.02
Normalized Net Income, 3 Yr. CAGR %	25.79	31.24	10.87	5.05	3.02
Diluted EPS Before Extra, 3 Yr. CAGR %	-10.87	-2.26	-14.22	-11.2	-7.73
Inventory, 3 Yr. CAGR %	-62.34	-	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	140.74	-20.29	-11.09	-18.13	-26.36
Total Assets, 3 Yr. CAGR %	52.69	58.75	32.18	-28.69	-27.52
Tangible Book Value, 3 Yr. CAGR %	51.91	54.32	29.85	-31.18	-29.9
Common Equity, 3 Yr. CAGR %	50.7	52.66	28.64	-31.29	-30.04
Cash From Operations, 3 Yr. CAGR %	29.3	33.74	40.24	2.11	-4.3
Capital Expenditures, 3 Yr. CAGR %	-2.16	-43.95	16.57	18.13	-31.06
Levered Free Cash Flow, 3 Yr. CAGR %	-15.15	50.45	110.27	37.03	-14.23
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.28	50.45	110.27	37.03	-14.23
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	93.85	35.47	27.8	10.87
EBITA, 5 Yr. CAGR %	-	93.85	35.54	27.77	10.74
EBIT, 5 Yr. CAGR %	-	92.55	35.27	27.63	10.65
Earnings From Cont. Operations, 5 Yr. CAGR %	-	76.38	12.09	21.8	10.38
Net Income, 5 Yr. CAGR %	-	76.38	12.09	21.8	10.38
Normalized Net Income, 5 Yr. CAGR %	-	76.38	12.09	21.8	10.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-	28.44	-15.85	-0.67	-10.87
Net Property, Plant and Equip., 5 Yr. CAGR %	-	73.51	67.52	-19.65	-24.44
Total Assets, 5 Yr. CAGR %	-	80.69	8.26	15.5	8.25
Tangible Book Value, 5 Yr. CAGR %	-	89.27	5.31	11.85	6.9
Common Equity, 5 Yr. CAGR %	-	78.83	4.87	11	6.14
Cash From Operations, 5 Yr. CAGR %	-	80.78	18.24	17.1	21.18
Capital Expenditures, 5 Yr. CAGR %	-	25.56	36.06	-45.03	-9.62
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	14.71	14.37	51.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	14.6	14.37	51.88